Response and Skin Toxicity Related Protein Signature in Late Stage Melanoma Patients after Anti-PD-1 Treatment - Biognosys

Response and Skin Toxicity Related Protein Signature in Late Stage Melanoma Patients after Anti-PD-1 Treatment

Case Studies

E-poster #1623 presented at AACR 2021

E-poster session April 10, 8:30 AM – 11:59 PM US EDT: PO.IM02.03 – Immune Checkpoints
Presenter: Kamil Sklodowski

A collaboration with:  Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy; NanoString Technologies, Seattle, WA

Abstract

 

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More